US Takes Control of Venezuela
Hours after President Donald Trump stunned the world by saying the US plans to “run” Venezuela, uncertainty over what that means and who is in charge loomed over the South American nation.
Ousted Venezuelan President Nicolás Maduro was an indicted prisoner on a flight bound for New York by the time his Vice President Delcy Rodríguez – who Trump said would partner with Washington to “make Venezuela great again” – denounced the intervention as “barbaric” and a “kidnapping.”
The White House offered few details about managing an oil-producing nation of about 30 million people. A US official stated Secretary of State Marco Rubio – a longtime critic of Maduro and Hugo Chavez – would lead the governance’s efforts.
Currently,there are no plans for American troops or administrators in Venezuela. However, Trump emphasized a focus on the country’s petroleum, stating the US would have a “presence in Venezuela as it pertains to oil.” This could expand the role of Chevron Corp., which currently operates in Venezuela under sanctions waivers, and other major American oil companies.
Trump’s reluctance to deploy troops and his dismissal of opposition leader maria corina Machado as unprepared for power suggest he favors working with Rodríguez and other Maduro loyalists over complete regime change.Maduro was in US custody in Manhattan by Saturday evening, according to a source familiar with the matter.
“Trump is essentially trying to control the vice president and people around her through carrots and sticks to get the outcomes the United States wants,” said Matthew Kroenig, vice president and senior director of the Atlantic Council’s Scowcroft Centre for Strategy and Security. “We’ll see if it effectively works.”
Trump confirmed this approach in remarks to the New York Post, stating US troops wouldn’t be necessary if Rodríguez “does what we want.”
This strategy is a notable gamble, especially for a president who campaigned on ending “forever wars” but has since authorized military strikes in iran, Yemen, Nigeria, and the Caribbean Sea.
Venezuela has endured decades of mismanagement, damaging its oil infrastructure, causing hyperinflation, and prompting millions to migrate. A government collapse following the US intervention risks further turmoil.
Related reading
- Paju Citizens Vote to Relocate JC Monument to Restore 3.1 Movement Historic Site
- Bridging the Gap Between Education and Employment
- Trump Rejects AI Safety Warnings and Vows to Maintain US Lead Over China (archyde.com)
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)